In contrast, Yuree et al. determined that UPK1A-AS1 functions as a tumor inhibitor by enhancing the mRNA stability of UPK1A under hypoxic conditions in lung and bladder carcinoma cells [45]. Here, UPK1A is linked to urinary bladder carcinoma.